Cargando…
Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use
ABSTRACT: Multipotent mesenchymal stromal cells (MSC) offer new therapeutic opportunities based on their ability to modulate an imbalanced immune system. Immunomodulatory potency is typically demonstrated in vitro by measuring the presence of surrogate markers (i.e., indoleamine-2,3-dioxygenase, IDO...
Autores principales: | Torrents, Sílvia, del Moral, Andrés Escudero, Codinach, Margarita, Rodríguez, Luciano, Querol, Sergi, Vives, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148700/ https://www.ncbi.nlm.nih.gov/pubmed/37120479 http://dx.doi.org/10.1007/s12026-023-09385-1 |
Ejemplares similares
-
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019) -
A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
por: Kizilay Mancini, Özge, et al.
Publicado: (2017) -
CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells
por: Psaroudis, Rose Triantafillia, et al.
Publicado: (2022) -
Development of an advanced cell therapy product indicated for the treatment of gonarthrosis
por: Vives, Joaquim, et al.
Publicado: (2015) -
Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell
por: Hansen, Stine Bangsgaard, et al.
Publicado: (2022)